GLYCOREX TRANSPLANTATION
Glycorex Transplantation AB (publ) is a medical technology company that conducts research, development, production and sales, especially in the field of organ transplantation. The company's main product, Glycosorb ยฎ -ABO, enables transplants across the blood group boundaries. This product has been used clinically since the fall of 2001 and enabled more than 3,500 blood group incompatible transplants with excellent clinical results. The company also develops products within universal blood plasma and products for specific treatment of autoimmune diseases, specifically Myasthenia gravis.
GLYCOREX TRANSPLANTATION
Social Links:
Industry:
Biotechnology Clinical Trials Health Care Manufacturing Medical Pharmaceutical
Founded:
1996-01-01
Address:
Lund, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.glycorex.se
Total Employee:
11+
Status:
Active
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Cision
Similar Organizations
Body Surface Translations
Body Surface Translations is a biomedical device company.
Promedim
Promedim is advanced cloud-based technology, integrated control centre.
Current Employees Featured
Founder
Official Site Inspections
http://www.glycorex.se
- Host name: akilles.oderland.com
- IP address: 91.201.60.23
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm

More informations about "Glycorex Transplantation"
Home - Glycorex Transplantation AB
Glycorexโs unique molecular level technology that specifically selects and removes antibodies in the blood has opened up revolutionary treatments and ... Scheelevägen 27 | SE-223 63 Lund, โฆSee details»
Board of Directors and CEO - Glycorex โฆ
Mar 29, 2021 Background and education: Founder and former CEO and Development and Product Manager at Glycorex โฆSee details»
Corporate Governance - Glycorex Transplantation AB
Mar 29, 2021 +46 46 286 52 30 [email protected]. About Glycorex. Market strategy; Investors. Financial reports; The Share โ information; Presentations; Corporate Governance; Board of โฆSee details»
Glycorex Transplantation AB - A Company At Ideon
Glycorex Transplantation AB (publ) is a medical technology company involved in development, production and sales in the fields of organ transplantation and. Stories & News; ...See details»
Glycorex AB - A Company At Ideon - Ideon Science Park
Glycorex AB. Address. Scheelevägen 27, 223 70 Lund. Building. Gateway. Company website. www.glycorex.se. Phone. 046-286 5230. E-mail. [email protected]. About Ideon. โฆSee details»
Glycorex Transplantation - Crunchbase Company โฆ
Glycorex Transplantation AB (publ) is a medical technology company that conducts research, development, production and sales, especially in the field of organ transplantation. The company's main product, Glycosorb ® -ABO, โฆSee details»
Glycorex Aktiebolag - Företagsinformation - allabolag.se
Glycorex Aktiebolag,556420-0235 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, varumärken, adress mm för Glycorex Aktiebolag Sök Få mer โฆSee details»
Glycorex Transplantation AB - ngm.se
Glycorex Transplantation är ett bioteknikbolag. Idag bedriver bolaget forskning, utveckling och marknadsföring inom området för organtransplantation. Bolagets huvudprodukt Glycosorb โฆSee details»
Glycorex Transplantation AB (publ) - Företagsinformation
Glycorex Transplantation AB (publ),556519-7372 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, varumärken, adress mm för Glycorex Transplantation โฆSee details»
Glycorex Transplantation AB (publ) - LinkedIn
Glycorex Transplantation AB (publ) is a globally recognized medical technology company headquartered in Lund, Sweden, with a unique know-how in the fields of biologically active โฆSee details»
About Glycorex - Glycorex Transplantation AB
Glycorex has recently launched a new product version designed to be used for donated plasma to produce universal blood plasma that can be given regardless of the recipientโs blood group, โฆSee details»
Glycorex Aktiebolag - 556420-0235 - Trelleborg - Se Nyckeltal ...
Allabolag.se ger dig företagsinformation om Glycorex Aktiebolag, 556420-0235. Hitta adress på karta, kontaktinfo, nyckeltal och befattningar.See details»
Glycorex AB - Företagsinformation | hitta.se
Glycorex AB (556420-0235). Se omsättning, bokslut, styrelse, m.m, Ladda ner gratis årsredovisningar.See details»
Glycorex Transplantation AB | Nordic Growth Market - ngm.se
Glycorex Transplantation is a biotechnology company. Currently, the company conducts research, development and marketing within the field of organ transplantation. The main product of the โฆSee details»
Oenighet i transplantationsbolag โ vd och styrelse hoppar av
Oct 16, 2023 Glycorex har utvecklat en medicinteknisk produkt för att möjliggöra organtransplantationer över blodgruppsgränserna. Den används framförallt vid โฆSee details»
Glycorex stärker organisationen för att lägga ytterligare kraft โฆ
Jan 31, 2023 Den 8 december 2022 tillträdde Johan Lavén som ny vd på Glycorex med uppdrag att genomföra bolagets tillväxtstrategi genom att expandera bolagets verksamhet inom โฆSee details»
Om Glycorex - Glycorex Transplantation AB
Glycorex har nyligen lanserat en lösning för behandling av blodgivarblod som innebär att all blodplasma som produceras vid blodgivarcentraler kan ges till samtliga patienter โ oavsett โฆSee details»
Glycorex Transplantation - placera.se
Dec 21, 2021 E-mail: [email protected], phone: 046-286 52 30 Brief information about the company Glycosorb® ABO is one of Glycorex Transplantation AB's self-developed proprietary โฆSee details»
Glycorex Transplantation - Cision News
Glycorex är ett globalt medicintekniskt bolag grundat 1996 med huvudkontor i Lund, Sverige. Bolaget har en unik kunskap inom biologiskt aktiva kolhydrater och extrakorporeala โฆSee details»
Enabling transplants across blood groups is no longer science fiction
CEO Geert Nygaard joined Glycorex in December 2021. Since then, he has worked together with his team to define the way forward for the company. In this interview, Geert talks about โฆSee details»